ADMA Biologics: Underfollowed And Undervalued Before Bivigam PDUFA [Seeking Alpha]
ADMA Biologics Inc (ADMA)
Last adma biologics inc earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.admabiologics.com
Company Research
Source: Seeking Alpha
ADMA Biologics: Underfollowed And Undervalued Before Bivigam PDUFASummaryADMA Biologics' PDUFA for BIVIGAM (IV immune globulin) in treating primary humoral immune deficiency is projected for December 18th.ADMA has another PDUFA in April for its RI-002 hyperimmune IV immune globulin product.The immune globulin (IG) market in the U.S. is strong, and the list of uses is expanding. ADMA aims to have two IVIG products launched by the end of 2019.I attempt to provide a couple valuations for the company and take a look at the charts for signs of an entry point.
Show less
Read more
Impact Snapshot
Event Time:
ADMA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADMA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADMA alerts
High impacting ADMA Biologics Inc news events
Weekly update
A roundup of the hottest topics
ADMA
News
- ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- ADMA Biologics, Inc. (NASDAQ: ADMA) had its price target raised by analysts at Raymond James from $8.00 to $10.00. They now have a "strong-buy" rating on the stock.MarketBeat
- ADMA Biologics, Inc. (NASDAQ: ADMA) had its price target raised by analysts at Cantor Fitzgerald from $8.00 to $10.00. They now have an "overweight" rating on the stock.MarketBeat
- ADMA Biologics, Inc. (NASDAQ: ADMA) had its price target raised by analysts at Mizuho from $10.00 to $12.00. They now have a "buy" rating on the stock.MarketBeat
- ADMA Biologics, Inc. (NASDAQ: ADMA) had its price target raised by analysts at HC Wainwright from $7.50 to $10.00. They now have a "buy" rating on the stock.MarketBeat
ADMA
Earnings
- 5/9/24 - Beat
ADMA
Sec Filings
- 5/9/24 - Form 10-Q
- 5/9/24 - Form 8-K
- 4/15/24 - Form ARS
- ADMA's page on the SEC website